330 related articles for article (PubMed ID: 28739222)
21. Muscle wasting in cancer.
Johns N; Stephens NA; Fearon KC
Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
[TBL] [Abstract][Full Text] [Related]
22. Circulating factors in cancer cachexia: recent opportunities for translational research.
Coêlho MC; de Aquino GP; Santos AS; Seelaender M
Curr Opin Clin Nutr Metab Care; 2024 May; 27(3):226-233. PubMed ID: 38547331
[TBL] [Abstract][Full Text] [Related]
23. Aerobic exercise training as therapy for cardiac and cancer cachexia.
Alves CR; da Cunha TF; da Paixão NA; Brum PC
Life Sci; 2015 Mar; 125():9-14. PubMed ID: 25500304
[TBL] [Abstract][Full Text] [Related]
24. Biomarkers for cancer cachexia: is there also a genetic component to cachexia?
Tan BH; Deans DA; Skipworth RJ; Ross JA; Fearon KC
Support Care Cancer; 2008 Mar; 16(3):229-34. PubMed ID: 18071761
[TBL] [Abstract][Full Text] [Related]
25. Cachexia in patients with oesophageal cancer.
Anandavadivelan P; Lagergren P
Nat Rev Clin Oncol; 2016 Mar; 13(3):185-98. PubMed ID: 26573424
[TBL] [Abstract][Full Text] [Related]
26. The complex liaison between cachexia and tumor burden (Review).
De Lerma Barbaro A
Oncol Rep; 2015 Oct; 34(4):1635-49. PubMed ID: 26239384
[TBL] [Abstract][Full Text] [Related]
27. Zinc-α2-glycoprotein as a marker of fat catabolism in humans.
Cabassi A; Tedeschi S
Curr Opin Clin Nutr Metab Care; 2013 May; 16(3):267-71. PubMed ID: 23448999
[TBL] [Abstract][Full Text] [Related]
28. Targets in clinical oncology: the metabolic environment of the patient.
Argilés JM; Busquets S; Moore-Carrasco R; Figueras M; Almendro V; López-Soriano FJ
Front Biosci; 2007 May; 12():3024-51. PubMed ID: 17485280
[TBL] [Abstract][Full Text] [Related]
29. Current perspectives of catabolic mediators of cancer cachexia.
Lelbach A; Muzes G; Feher J
Med Sci Monit; 2007 Sep; 13(9):RA168-173. PubMed ID: 17767131
[TBL] [Abstract][Full Text] [Related]
30. Cancer cachexia: developing multimodal therapy for a multidimensional problem.
Fearon KC
Eur J Cancer; 2008 May; 44(8):1124-32. PubMed ID: 18375115
[TBL] [Abstract][Full Text] [Related]
31. Cachexia versus sarcopenia.
Rolland Y; Abellan van Kan G; Gillette-Guyonnet S; Vellas B
Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):15-21. PubMed ID: 21076295
[TBL] [Abstract][Full Text] [Related]
32. Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer.
Fukushima H; Takemura K; Suzuki H; Koga F
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275370
[TBL] [Abstract][Full Text] [Related]
33. The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
Esper DH; Harb WA
Nutr Clin Pract; 2005 Aug; 20(4):369-76. PubMed ID: 16207677
[TBL] [Abstract][Full Text] [Related]
34. Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15.
Tsai VW; Lin S; Brown DA; Salis A; Breit SN
Int J Obes (Lond); 2016 Feb; 40(2):193-7. PubMed ID: 26620888
[TBL] [Abstract][Full Text] [Related]
35. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
[TBL] [Abstract][Full Text] [Related]
36. On our way to targeted therapy for cachexia in cancer?
Boddaert MS; Gerritsen WR; Pinedo HM
Curr Opin Oncol; 2006 Jul; 18(4):335-40. PubMed ID: 16721127
[TBL] [Abstract][Full Text] [Related]
37. [Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)].
Argilés JM; Busquets S; López-Soriano FJ; Figueras M
Nutr Hosp; 2006 May; 21 Suppl 3():38-45. PubMed ID: 16768029
[TBL] [Abstract][Full Text] [Related]
38. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia.
Acharyya S; Butchbach ME; Sahenk Z; Wang H; Saji M; Carathers M; Ringel MD; Skipworth RJ; Fearon KC; Hollingsworth MA; Muscarella P; Burghes AH; Rafael-Fortney JA; Guttridge DC
Cancer Cell; 2005 Nov; 8(5):421-32. PubMed ID: 16286249
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
[TBL] [Abstract][Full Text] [Related]
40. Muscle protein kinetics in cancer cachexia.
Johns N; Stephens NA; Preston T
Curr Opin Support Palliat Care; 2012 Dec; 6(4):417-23. PubMed ID: 23123817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
